ChemicalBook > CAS DataBase List > Ebronucimab

Ebronucimab

Product Name
Ebronucimab
CAS No.
2304800-90-4
Chemical Name
Ebronucimab
Synonyms
Ebronucimab;Research Grade Ebronucimab;Research Grade Ebronucimab (DHJ24009)
CBNumber
CB010617027
Formula Weight
0
MOL File
Mol file
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

Ebronucimab Chemical Properties,Usage,Production

Uses

Ebronucimab (AK102) is an IgG1-λ2 antibody targeting PCSK9 and is primarily expressed by CHO DG44 (Chinese Hamster Ovary) cells[1].

References

[1] Ebronucimab. IMGT.

Ebronucimab Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

Ebronucimab Suppliers

China 9 Global 9
ShangHai Biochempartner Co.,Ltd
Tel
177-54423994 17754423994
Fax
QQ:2853530913
Email
2853530910@QQ.com
Country
China
ProdList
8000
Advantage
62
Guangzhou Hongyuan Chemical Co.,Ltd
Tel
15817493340
Email
981810490@qq.com
Country
China
ProdList
1566
Advantage
58
Wuhan Chemstan Biotechnology Co., Ltd.
Tel
027-65317797 15926423062
Fax
QQ：422450190
Email
422450190@qq.com
Country
China
ProdList
10308
Advantage
58
Biolab Reagents
Tel
027-65279366 18108604356
Email
products@biolabreagent.com
Country
China
ProdList
9868
Advantage
58
Wanxin Biotechnology (Jiaxing) Co., LTD
Tel
0573-83568680 18057391398
Email
3956524501@qq.com
Country
China
ProdList
1442
Advantage
58
Atagenix Laboratories
Tel
027-87008169 17762441161
Email
info@atagenix.com
Country
China
ProdList
10001
Advantage
58
AntibodySystem Laboratories SAS
Tel
33175446423
Email
support@antibodysystem.com
Country
China
ProdList
6739
Advantage
58
Cell Sciences
Tel
9785721070
Email
info@cellsciences.com
Country
China
ProdList
6308
Advantage
58
Kangrong Oriental (Guangdong) Pharmaceutical Co., Ltd.
Tel
Country
CHINA
ProdList
1
Advantage
58

2304800-90-4, EbronucimabRelated Search:

Alsevalimab Etigilimab Mipasetamab Docaravimab Adintrevimab Pimurutamab elsilimomab Sotevtamab Tesidolumab Lulizumab Pegol

  • Ebronucimab
  • Research Grade Ebronucimab (DHJ24009)
  • Research Grade Ebronucimab
  • 2304800-90-4